Company intelligence / Profile preview

Mildendo Gesellschaft für mikrofluidische Systeme mbH

Jena, Thuringia, Germany

Ownership: Private
Development stage: Other

Overview

Mildendo develops and manufactures microfluidic systems and polymer-based microtechnical components used as enabling technology for analytical and real-time testing applications; it does not appear to run its own therapeutic or diagnostic trials.[4][10]

Industry: Chemicals & Materials

Partnerships

Keystone Labs (EVIO Canada) – partnership to complete development of a real-time testing platform for cannabinoid profiling and plant health monitoring.[10]Università degli Studi di Padova – collaborative project participant.[9]

Beyond the preview

Go deeper on Mildendo Gesellschaft für mikrofluidische Systeme mbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mildendo Gesellschaft für mikrofluidische Systeme mbH.

Explore the full profile